2005•Transactions of the Royal Society of Tropical Medicine and HygieneRequires access

Cure of antimony-unresponsive Indian post-kala-azar dermal leishmaniasis with oral miltefosine

Shyam Sundar, Kailash Kumar, Jaya Chakravarty, Dipti Agrawal, Shrinkhla Agrawal, Amit Chhabra, Vikram Singh

Abstract

We report the case of a patient with Indian post-kala-azar dermal leishmaniasis (PKDL) who failed to show any response to 2 months' treatment with sodium stibogluconate. Six months later he was treated with oral miltefosine on a compassionate basis as an off-label indication. Miltefosine was given 100mg daily in divided doses for an initial 8 weeks. Due to insufficient response, the treatment was extended up to a total of 12 weeks. The patient showed an excellent response to treatment, and after 12 months of follow-up there was complete healing of all cutaneous lesions. Oral miltefosine appears to be an important alternative for the treatment of PKDL in India and confirmatory studies in controlled clinical trials are needed.

About this research paper

What this paper is about

Why it matters

OpenAlex reports 36 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Miltefosine, Sodium stibogluconate, Medicine, Leishmaniasis, Dermatology, Visceral leishmaniasis, Clinical trial, Surgery